We are live on
!
Find out more
WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
1-Year Est. Return
17.41%
This Fund
S&P 500
This Quarter
Est. Return
+19.42%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$2.33B
AUM Growth
+$599M
(+35%)
Cap. Flow
+$350M
Cap. Flow
% of AUM
15.01%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
6
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$203M |
| 2 |
Theravance Biopharma
TBPH
|
+$74.6M |
| 3 |
NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
|
+$26.2M |
| 4 |
Alkermes
ALKS
|
+$23M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$12.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.96% |
| 2 | Consumer Staples | 33.04% |
Similar funds
LCM
GWA
NC
IPC
AEPG
AR
KCM
COI
Woodford Investment Management's Q4 2015 Portfolio in Review
As of Q4 2015, Woodford Investment Management held 6 positions worth $2.33B, up 35% from $1.73B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Woodford Investment Management deployed $350M of net new capital in Q4 2015, adding to 6 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 58% a quarter earlier, followed by Consumer Staples.
- Woodford Investment Management added most to AbbVie in Q4 2015, an estimated $203M increase.
- Woodford Investment Management's ten largest holdings make up 100% of its $2.33B portfolio in Q4 2015.
- Woodford Investment Management opened 0 new positions and closed 0 in Q4 2015.
- Woodford Investment Management's portfolio value rose 35% quarter-over-quarter to $2.33B.
Based on Woodford Investment Management's 13F filing for Q4 2015, filed 16 Feb 2016.